J&J | JNJ - Kas Dan Setara





Kas Dan Setara Perubahan Tanggal
AbbVie USD 9.39B 4.16B 2026-03
Abbott USD 6.8B 1.72B 2026-03
Amgen USD 12.04B 2.91B 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Baxter International USD 2.02B 51M 2026-03
Bayer EUR 6.67B 774M 2025-12
Becton, Dickinson and Co. USD 813M 73M 2026-03
Biogen USD 3.38B 374.2M 2026-03
Boston Scientific USD 1.45B 512M 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
CONMED USD 40.82M 1.89M 2025-12
Cooper Companies USD 110.6M 14.3M 2025-09
Dexcom USD 1.12B 200.5M 2026-03
Edwards Lifesciences USD 2.4B 538M 2026-03
Eli Lilly USD 5.28B 1.99B 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Globus Medical USD 560.95M 34.79M 2026-03
Insulet USD 480.4M 235.7M 2026-03
Integra LifeSciences USD 236.81M 1.76M 2026-03
Intuitive Surgical USD 7.98B 1.05B 2026-03
J&J USD 21.69B 1.98B 2026-03
Medtronic USD 1.15B 135M 2025-12
Merck USD 5.33B 9.24B 2026-03
Merit Medical Systems USD 488.08M 41.68M 2026-03
Novartis USD 6.88B 4.56B 2026-03
Pfizer USD 1.7B 561M 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Stryker USD 2.88B 1.13B 2026-03
Tandem Diabetes Care USD 179.32M 88.69M 2026-03
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03
Zimmer Biomet Holdings USD 424.2M 167.7M 2026-03
Zoetis USD 1.94B 369M 2026-03